Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Lexi Ventures

Status
ACTIVE
Global HQ
Menlo Park, United States
Countries of investment
  • USA
Investment stages
  • Pre-Seed
  • Seed
Industries
  • Fintech
  • AI
  • Health Tech
About
Lexi Ventures is an investment firm focused on the next great technology revolution. They invest in a balanced portfolio that includes therapeutics, diagnostics, food, materials, software, and more. They are committed to effective philanthropy and believe that investing is the most effective way to achieve it. Their notable investments include Taxa Technologies, Syntensor, Glyphic Biotechnologies, and ParcelBio.
Min check size
$10K
Max check size
$1M
Fund size
NPS

Investment Thesis

They invest in Seed stage US companies applying genomics, genetic engineering, or synbio to health and other industries such as food/ag, waste/recycling, and biomaterials. In general, startups working on DNA, RNA, proteins, and omics.
Lead investor
Co Invest
Number of exits
Preferred contact method
Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp